Skip to main content

Monsanto backs new company focused on gene editing, not GMOs

CHICAGO, March 20 (Reuters) - Monsanto Co will fund a new U.S. company that aims to develop crops using technology known as gene editing, rather than the genetic modification that helped it become the world's biggest seed seller.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.